Caring for AML Patients During the COVID-19 Crisis: An American and Italian ExperienceOncology Published on 2020-09-022022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] acute myeloid leukemia acute respiratory syndrome AML approach Care Complication coronavirus COVID-19 experience Healthcare provider immune impacted increased risk intensity Italian Italy leukemia malignancy oncology pandemic Patient resources SARS-CoV-2 SARS-CoV2 subsequent the disease the United State Treatment two group unique [DOI] 10.3389/fonc.2020.01689 PMC 바로가기 [Article Type] Oncology
Forecasting the timeframe of 2019-nCoV and human cells interaction with reverse engineeringReview Published on 2020-09-012023-07-13 Journal: Progress in Biophysics and Molecular Biology [Category] SARS, [키워드] Dynamical analysis Kinetic modelling MCMC analysis monoclonal antibody Numerical simulations SARS-CoV2 [DOI] 10.1016/j.pbiomolbio.2020.04.002 PMC 바로가기 [Article Type] Review
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adultsCOVID-19에 감염된 어린이의 면역 반응은 감염된 성인보다 낮은 수준의 T 세포 활성화가 특징입니다Article Published on 2020-09-012022-09-12 Journal: European Journal of Immunology [Category] SARS, 진단, [키워드] activated activated T cell addition Adults CCL5/RANTES CD4 CD8 Cell characterized children children with COVID-19 COVID-19 CXCL9 CXCL9/MIG expressing expression feature IL-12 IL-1β immune response immunological SARS-CoV-2 SARS-CoV2 T-cell activation T-cell activation. Th1 with COVID-19 [DOI] 10.1002/eji.202048724 PMC 바로가기 [Article Type] Article
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab알렘투주맙으로 치료받은 중증 다발성 경화증 환자의 잠재적인 COVID-19 감염Article Published on 2020-09-012022-09-12 Journal: Multiple sclerosis and related disorders [Category] 진단, [키워드] Administered age Alemtuzumab asked case sery changes in Clinical course COVID-19 COVID-19 infection COVID-19 pandemic Cytokine storm Defense Diagnosis Disease diagnosis dose EDSS evaluate females Frequency Hospital admission immune immune system immunosuppressive induce lymphocyte Lymphocyte count Mild symptom Multiple multiple sclerosis Patient patients treated positive Potential preliminary findings questionnaire receiving required Research SARS-CoV2 sclerosis severity of COVID-19 statistically significant difference Symptom symptoms of COVID-19 therapy treated Treatment Two patient with COVID-19 [DOI] 10.1016/j.msard.2020.102297 PMC 바로가기 [Article Type] Article
Increase in COVID-19 inpatient survival following detection of Thromboembolic and Cytokine storm risk from the point of admission to hospital by a near real time Traffic-light System (TraCe-Tic)Research article Published on 2020-09-012022-10-05 Journal: The Brazilian journal of infectious diseases : an [Category] SARS, 치료기술, [키워드] Admission Admissions age and sex analyses anticoagulation benefit C-reactive protein Care category Clinicians confidence interval COVID-19 COVID-19 positive patient criteria CRP D-dimer death diabete died discharge evaluate evaluated ferritin FLAG hospital hypertension implementation increase Intervention male males management median age Mortality older patients outcome Patient potential risk Probability reached real time reduction in Result risk SARS-CoV2 survival survived System the patient therapy Thromboembolism Trigger [DOI] 10.1016/j.bjid.2020.07.010 [Article Type] Research article
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?Review Published on 2020-08-282022-10-28 Journal: Vaccine: X [Category] COVID-19, [키워드] antibodies antibody antibody production Antibody Response Antibody-dependent enhancement Antigen Blood boost breadth CD4 CD8 CD8 T-cell CD8 T-cells Cell-mediated immunity clinical disease Clinical outcome Clinical severity convalescent Coronavirus infection Coronavirus infections correlated Coverage COVID-19 cross-reactive described develop disease Durable immunity epitope Human immune protection immune response immunized induce Laboratory less marker mild infections natural infection neutralizing antibody nightmare pathogenic pathology Phase 2 Progress Protective protective immunity public health resulting SARS SARS-CoV-2 SARS-CoV2 Spike protein Support T cell lifespan T cell response T-cell epitopes T-cell Response T-cells trials vaccination Vaccine vaccine candidate Vaccines yellow Yellow Fever Vaccine [DOI] 10.1016/j.jvacx.2020.100076 PMC 바로가기 [Article Type] Review
COVID-19: dealing with a potential risk factor for chronic neurological disordersReview Published on 2020-08-272022-10-29 Journal: Journal of Neurology [Category] COVID-19, MERS, SARS, [키워드] acute respiratory distress Autoimmune Central nervous system clinical evidence complex consequence COVID-19 Demyelination diagnosing disorders Encephalitis Gut headache immunopathology increasingly initiated multiple sclerosis Narcolepsy neurodegeneration neurodegenerative disorders Neuroinflammation Neurological disorder Neurological disorders neurological manifestation Parkinson’s disease Parkinson’s disease pathogenic mechanism patients with COVID-19 potential risk reported responsible risk factor Risk factors SARS-CoV2 SARS-CoV2 infection Seizures serology severe pneumonia sleepiness stroke susceptible individuals syndrome systemic inflammatory response tissue [DOI] 10.1007/s00415-020-10131-y PMC 바로가기 [Article Type] Review
The Potential Role of Immune Alteration in the Cancer–COVID19 Equation—A Prospective Longitudinal StudyArticle Published on 2020-08-262022-10-31 Journal: Cancers [Category] COVID-19, [키워드] alteration Analysis anti-cancer treatment Asymptomatic Blood Cancer Cancer center cancer patient Cancer patients cancer treatment Cohort collected Course COVID-19 infection COVID19 Cytometry demographic data demonstrated develop enrolled Evidence expression healthcare healthcare worker high-risk population host response IgA IgG IgM Immune cell Immune profile immune response immunological Immunomodulatory agent Immunomodulatory agents Inconclusive Infection intravenous lack longitudinal myeloid cell oncology pandemic Patient performed Perspective Potential profile Prospective reduction reduction in reported risk role SARS-CoV-2 SARS-CoV2 serology simple study period surface markers symptom severity symptomatic case treated Treatment was determined were assessed [DOI] 10.3390/cancers12092421 PMC 바로가기 [Article Type] Article
What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a VaccinologistImmunology Published on 2020-08-262022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, MERS, SARS, [키워드] COVID-19 inactivated virus vaccines QS21 saponins SARS-CoV2 Universal vaccine urge [DOI] 10.3389/fimmu.2020.02173 PMC 바로가기 [Article Type] Immunology
Recent advances in therapeutic modalities and vaccines to counter COVID-19/SARS-CoV-2Review Published on 2020-08-262023-06-15 Journal: Human vaccines & immunotherapeutics [Category] MERS, SARS, [키워드] control precautions COVID-19 Respiratory disease SARS-CoV2 therapeutic regimens viral vaccines [DOI] 10.1080/21645515.2020.1794685 PMC 바로가기 [Article Type] Review